Coronary cardiac allograft vasculopathy versus native atherosclerosis: Difficulties in classification

Virchows Archiv

Volumn 464, Issue 6, 2014, Pages 627-635

  Angelini, Annalisa ^a   Castellani, Chiara ^a   Fedrigo, Marny ^a   De Boer, Onno J ^b   Meijer Jorna, Lorine B ^b   Li, Xiaofei ^b   Valente, Marialuisa ^a   Thiene, Gaetano ^a   Van Der Wal, Allard C ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adventitia remodeling; Atherosclerosis; Cardiac allograft vasculopathy; Inflammation; Intraplaque hemorrhage

Indexed keywords

ACUTE HEART INFARCTION; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BLEEDING; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE CLASSIFICATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIA; PATHOLOGIST; PRIORITY JOURNAL; REVIEW; STENOSIS; SUDDEN CARDIAC DEATH;

CORONARY ARTERY DISEASE; GRAFT REJECTION; HEART DISEASES; HEART TRANSPLANTATION; HUMANS;

EID: 84902356914     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1586-6     Document Type: Review

References (60)

1. RahmaniM, Cruz RP, Granville DJ, McManus BM (2006) Allograft vasculopathy versus atherosclerosis. Circ Res 99:801-815 (Pubitemid 44556379)
2. Mitchell NR (2013) Learning from rejection: what transplantation teaches us about (other) vascular pathologies. J Autoimmun 45:80-89
3. Suzuki J, Isobe M, Morishita R, Nagai R (2010) Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. Circ J 74:233-239
4. Ardehali A (1995) Heart transplantation: accelerated graft atherosclerosis. Adv Card Surg 6:195-205
5. Grant SC, Brooks NH (1993) Accelerated graft atherosclerosis after heart transplantation. Br Heart J 69:469-470 (Pubitemid 23171131)
6. Rossignol DA, Kipreos B, Akosah K, Mohanty PK (1999) Accelerate transplant coronary artery disease and massive silent acute myocardial infarction in a heart transplant patient - a case report and brief review of literature. Angiology 50:947-953
7. Johnson MR (1992) Transplant coronary disease: nonimmunologic risk factor. J Heart Lung Transplant 11:S124-S132
8. Mitchell RN, Libby P (2007) Vascular remodeling in transplant vasculopathy. Circ Res 100:967-978 (Pubitemid 46598921)
9. McManus BM, Horley KJ, Wilson JE, Malcom GT, Kendall TJ, Miles RR, Winters GL, Costanzo MR, Miller LL, Radio SJ (1995) Prominence of coronary arterial wall lipids in human heart allograft. Implication for pathogenesis of allograft arteriopathy. Am J Pathol 147:293-308
10. Bundy RE, Marczin N, Birks EF, Chester AH, Yacoub MH (2000) Transplant atherosclerosis: role of phenotypicmodulation of vascular smooth muscle by nitric oxide. Gen Pharmacol 34:73-84
11. Weis M, von Sheidt W (1997) Cardiac allograft vasculopathy: a review. Circulation 96:2069-2077 (Pubitemid 27400772)
12. Fishbein GA, Fishbein MC (2009) Arteriosclerosis: rethinking the current classification. Arch Pathol Lab Med 133:1309-1316
13. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA (2010) International society for heart and lung transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 29:717-727
14. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak and intermediate lesions of atherosclerosis. A report from committee on vascular lesions of the council on atherosclerosis American heart association. Circulation 89:2462-2478 (Pubitemid 24142837)
15. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from committee on vascular lesions of the council on atherosclerosis American heart association. Artherioscler Thromb Vasc Biol 15:1512-1531
16. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, International Society of Heart and Lung Transplantation (2012) The registry of the international society for heart and lung transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 31:1052-1064
17. Caforio AL, Tona F, Fortina AB, Angelini A, Piaserico S, Gambino A, Feltrin G, Ramondo A, Valente M, Iliceto S, Thiene G, Gerosa G (2004) Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4:962-970 (Pubitemid 38750168)
18. Schmauss D, Weis M (2008) Cardiac allograft vasculopathy. Recent developments. Circulation 117:2131-2141 (Pubitemid 351596195)
19. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262-1275 (Pubitemid 30262927)
20. Johnson DE, Gao SZ, Schroeder JS, DeCampliWM, Billingham ME (1989) The spectrum of coronary artery pathological findings in human cardiac allograft. J Heart Transplant 8:349-359 (Pubitemid 19247624)
21. LuW, Palatnik K, Fishbein GA, Lai C, Levi DS, Perens G, Alejos J, Kobashigawa J, Fishbein MC (2011) Diverse morphologic manifestation of cardiac allograft vasculopathy: a pathological study of 64 allograft hearts. J Heart Lung Transplant 30:1044-1050
22. Pucci AM, Forbes RD, Billingham ME (1990) Pathological features in long-term cardiac allograft. J Heart Transplant 9:339-345 (Pubitemid 20279758)
23. Haas M (2012) Pathological features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens 21:264-271
24. Stegall MD, Park WD, Larson TS, Gloor JM, Cornell LD, Sethi S, Dean PG, Prieto M, Amer H, Textor S, Schwab T, Cosio FG (2011) The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant 11:698-707
25. Tona F, Caforio AL, Montisci R, Angelini A, Ruscazio M, Gambino A, Ramondo A, Thiene G, Gerosa G, Iliceto S (2006) Coronary flow reserve by contrast-enhanced echocardiography: a new noninvasive diagnostic tool for cardiac allograft vasculopathy. Am J Transplant 6:998-1003 (Pubitemid 44356650)
26. Angelini A, Castellani C, Tona F, Gambino A, Caforio AP, Feltrin G, Della Barbera M, Valente M, Gerosa G, Thiene G (2007) Continous engraftment and differentiation of male recipient Y-chromosomepositive cardiomyocytes in donor female human heart transplants. J Heart Lung Transplant 26:1110-1118 (Pubitemid 350088516)
27. Gallo P, Agozzino L, Angelini A, Arbustini E, Bartoloni G, Bernucci P, Bonacina E, Bosman C, Catani G, di Gioia C, Giordana C, Leone O, Motta T, Pucci A, Rocco M (1997) Causes of late failure after heart transplantation: a ten-year survey. J Heart Lung Transplant 16: 1113-1121 (Pubitemid 27506298)
28. Virmani R, Kolodgie FD, BurkeAP, FinnAV, GoldHK, Tulenko TN, Wrenn SP, Narula J (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054-2061 (Pubitemid 41416300)
29. Yeagle PL (1985) Cholesterol and the cell membrane. Biochim Biophys Acta 822:267-287
30. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, Bult H (2003) Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23:440-446 (Pubitemid 36337220)
31. Koole D, Heyligers J, Moll F, Pasterkamp G (2012) Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. J Cardiovasc Med (Hagerstown) 13:635-639. doi:10.2459/JCM.0b013e3283590cd2
32. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316-2325 (Pubitemid 37509739)
33. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello C, Small R, Ferguson MS, Hatsukami TS (2005) Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high resolution magnetic resonance imaging study. Circulation 111:2768-2775 (Pubitemid 40791548)
34. Castellani C, Angelini A, de Boer OJ, van der Loos CM, Fedrigo M, Frigo AC, Meijer-Jorna LB, LiX, Ploegmakers HJ, Tona F, Feltrin G, Gerosa G, Valente M, Thiene G, van der Wal AC (2013) Intraplaque hemorrhage in cardiac allograft vasculopathy. Am J Transplant 14:184-192
35. van Loosdregt J, van Oosterhout MF, Bruggink AH, vanWichen DF, van Kuik J, de Koning E, Baan CC, de Jonge N, Gmelig-Meyling FH, de Weger RA (2006) The chemokine and chemokine receptor profile of infiltrating. Cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation 14:1599-1607 (Pubitemid 44547430)
36. De Boer OJ, Becker AE, van der Wal AC (2003) T lymphocytes in atherogenesis - functional aspects and antigenic repertoire. Cardiovasc Res 60:78-86 (Pubitemid 38373478)
37. Siow RCM, Churchman AT (2007) Adventitial growth factor signalling and vascular remodelling: potential perivascular gene transfer from outside-in. Cardiovasc Res 75:659-668 (Pubitemid 47238743)
38. Baikoussis N, Apostolakis EE, Papakonstantinou NA, Siminelakis SN, Arnaoutoglou H, Papadopoulos G, Goudevenos J, Dougenis D (2011) The implication of vasa vasorum in surgical diseases of the aorta. Eur J Cardiothorac Surg 40:412-417
39. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44 (Pubitemid 24026469)
40. Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ, UedaM, Becker AE (2003) Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy speciments of patients with unstable angina and acute myocardial infarction. Atherosclerosis 168:73-80 (Pubitemid 36555813)
41. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A (2009) Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol 53:1279-1286
42. Stocin PGI, Sharples LD, Schofield PM, Cary NR, Mullins PA, English TA, Wallwoek J, Large SR (1993) Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease. J Heart Lung Transplant 12:110-116 (Pubitemid 23099866)
43. Kfouri AG, HammondME, Snow GL, Drakos SG, Stehlik J, Fischer PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009) Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Transplant 28:781-784
44. Petrossian GA, Nichols AB, Marboe CC, Sciacca R, Rose EA, Smith CR, Cannon PJ, Reemtsma K, Powers ER (1989) Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 80(III):122-125 (Pubitemid 19280444)
45. Cherry R, Nielsen H, Reed E, Reemtsma K, Suciu-Foca N, Marboe CC (1992) Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 11:24-29
46. Wu GW, Kobashigawa JA, Fishbein MC, Patel JK, Kittleson MM, Reed EF, Kiyosaki KK, Ardehali A (2009) Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 28:417-422
47. Poelzl G, Ullrich R, Huber A, Ulmer H, Antretter H, Hoefer D, Mairinger T, Laufer G, Pachinger O, Schwarzacher S (2005) Capillary deposition of the complement fragment C4d in cardiac allograft biopsies is associated with allograft vasculopathy. Transpl Int 18:313-317 (Pubitemid 41726895)
48. Loupy A, Cazes A, Guillemain R, Amrein C, Hedjoudje A, TibleM, Pezzella V, Fabiani JN, Suberbielle C, Nochy D, Hill GS, Empana JP, Jouven X, Bruneval P, Duong Van Huyen JP (2011) Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 11:1478-1487
49. Tible M, Loupy A, Vernerey D, Suberbielle C, Beuscart T, Cazes A, Guillemain R, Amrein C, Pezzella V, Fabiani JN, Nochy D, Hill G, Empana JP, Jouven X, Charron D, Bruneval P, Duong Van Huyen JP (2013) Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation. J Heart Lung Transplant 32:769-776
50. Jindra PT, Jin YP, Rozengurt E, Reed EF (2008) HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol 180:2357-2366
51. Valenzuela NM, Reed EF (2013) Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol 1034:41-70
52. Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P (2008) Donor-specific HLA alloantibodies:long term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp Clin Transplant 6:229-235
53. Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sørensen K, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P, RAD B253 Study Group (2003) Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349:847-858 (Pubitemid 37025404)
54. Arora S, Erikstad I, Ueland T, Sigurdardottir V, Ekmehag B, Jansson K, Eiskjer H, Botker HE, Mortensen S-A, Saunamaki K, Gude E, Ragnarsson A, Solbu D, Aukrust P, Gullestad L (2012) Virtual Histology assessment of Cardiac Allograft vasculopathy following introduction of everolimus - results of a multicenter trial. Am J Transplant 12:2700-2709
55. Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, Murata A, Takeda Y, Ito T, Ehara M, Matsubara T, Terashima M, Suzuki T (2006) Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47:2405-2412 (Pubitemid 43866370)
56. Dong L, KerwinWS, Chen H, Chu B, Underhill HR, Neradilek MB, Hatsukami TS, Yuan C, Zhao XQ (2011) Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum - evaluation by using dynamic contrast-enhanced MR imaging. Radiology 260:224-231
57. Moguillansky D, Leng X, Carson A, Lavery L, Schwartz A, Chen X, Villanueva FS (2011) Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J 32:646-653
58. ten Kate GL, Sijbrands EJ, Valkema R, ten Cate FJ, Feinstein SB, van der Steen AF, Daemen MJ, Schinkel AF (2010) Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol 17:897-912
59. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, Malik S, Fuster V, Finn AV (2013) Histopathologic characteristics of atherosclerotic coronary disease and implication of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol 61:1041-1051
60. Castellani C, van der Wal AC, De Boer OJ, Fedrigo M, Thiene G, Valente M, Angelini A (2013) Virtual histology and the morphologic assessment of cardiac allograft vasculopathy. Am J Transplant 13:1109